Cite
HARVARD Citation
Jaraczewska-Baumann, M. et al. (n.d.). FRI0161 A Phase 1B/2A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XMAB®5871 in Patients with Rheumatoid Arthritis. Annals of the rheumatic diseases. p. 481. [Online].